These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8342067)

  • 1. Early detection of lung cancer.
    Szabo E; Birrer MJ; Mulshine JL
    Semin Oncol; 1993 Aug; 20(4):374-82. PubMed ID: 8342067
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational targets for the early detection of lung cancer.
    Mulshine JL; Linnoila RI; Jensen SM; Magnani JL; Tockman MS; Gupta PK; Scott FS; Avis I; Quinn K; Birrer MJ
    J Natl Cancer Inst Monogr; 1992; (13):183-90. PubMed ID: 1389692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tumor markers in lung cancer.
    Strauss GM; Skarin AT
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):507-32. PubMed ID: 8707770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
    Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using molecular markers in sputum for the early detection of lung cancer: a review.
    Kennedy TC; Hirsch FR
    Lung Cancer; 2004 Aug; 45 Suppl 2():S21-7. PubMed ID: 15552778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of lung cancer.
    Wistuba II; Gazdar AF
    Verh Dtsch Ges Pathol; 2000; 84():96-105. PubMed ID: 11217455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection.
    Gomperts BN; Spira A; Elashoff DE; Dubinett SM
    Cancer Prev Res (Phila); 2010 Apr; 3(4):420-3. PubMed ID: 20332300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical detection of lung cancer progression markers.
    Tockman MS
    J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes and tumour-suppressor genes in lung cancer.
    Nikliński J
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():1-7. PubMed ID: 9337518
    [No Abstract]   [Full Text] [Related]  

  • 12. New approaches for biomarker discovery in lung cancer.
    Valle RP; Chavany C; Zhukov TA; Jendoubi M
    Expert Rev Mol Diagn; 2003 Jan; 3(1):55-67. PubMed ID: 12528364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating DNA and lung cancer.
    Xue X; Zhu YM; Woll PJ
    Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early detection of occult lung cancer.
    Tockman MS; Mulshine JL
    Chest Surg Clin N Am; 2000 Nov; 10(4):737-49. PubMed ID: 11091923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern cytological diagnosis of lung cancer].
    Puchkov IuG; Bramberga VM; Shapiro NA; Shcherbakova MG; Krasil'nikova LA
    Vopr Onkol; 1982; 28(2):37-9. PubMed ID: 7039113
    [No Abstract]   [Full Text] [Related]  

  • 18. Early diagnosis of lung cancer by detection of tumor liberated protein.
    Tarro G; Perna A; Esposito C
    J Cell Physiol; 2005 Apr; 203(1):1-5. PubMed ID: 15389637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnostic markers for lung cancer in sputum and plasma.
    Wang YC; Hsu HS; Chen TP; Chen JT
    Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on screening for lung cancer.
    Midthun DE; Jett JR
    Semin Respir Crit Care Med; 2008 Jun; 29(3):233-40. PubMed ID: 18506661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.